ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $485,000 | +134.3% | 106,449 | +136.1% | 0.00% | – |
| Q4 2015 | $207,000 | +567.7% | 45,081 | +546.9% | 0.00% | – |
| Q4 2014 | $31,000 | -96.0% | 6,969 | -95.3% | 0.00% | -100.0% |
| Q3 2014 | $770,000 | +12.2% | 149,518 | +4.9% | 0.00% | 0.0% |
| Q2 2014 | $686,000 | +1272.0% | 142,549 | +618.9% | 0.00% | – |
| Q3 2013 | $50,000 | +22.0% | 19,830 | 0.0% | 0.00% | – |
| Q2 2013 | $41,000 | – | 19,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 1,047,732 | $5,333,000 | 2.30% |
| KOPP INVESTMENT ADVISORS LLC | 232,099 | $1,181,000 | 1.17% |
| GLOBEFLEX CAPITAL L P | 225,834 | $1,149,000 | 0.29% |
| KEMPNER CAPITAL MANAGEMENT INC. | 70,001 | $356,000 | 0.24% |
| Breithorn Capital Management | 63,324 | $322,000 | 0.24% |
| Acrospire Investment Management LLC | 55,444 | $282,000 | 0.19% |
| EAM Investors, LLC | 267,368 | $1,361,000 | 0.18% |
| Granahan Investment Management | 875,002 | $4,454,000 | 0.15% |
| Geduld E E | 15,000 | $76,000 | 0.08% |
| GILDER GAGNON HOWE & CO LLC | 872,009 | $4,439,000 | 0.08% |